Mesoblast (NASDAQ: MESO) reported Q1 EPS of ($0.03), $0.15 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.94 million versus the consensus estimate of $2.14 million.

For earnings history and earnings-related data on Mesoblast (MESO) click here.